Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
about
Outcomes, outcomes, every where, nor any stop to think?LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impactWhy Most Clinical Research Is Not UsefulCardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesCholesterol confusion and statin controversyEnd points for comparative effectiveness research in heart failureLong-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studiesBiased safety reporting in blinded randomized clinical trials: meta-analysis of angiotensin receptor blocker trialsSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsDesigning and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomesCholesterol paradox: a correlate does not a surrogate make.Delta inflation: a bias in the design of randomized controlled trials in critical care medicine.Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study.A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary interventionAspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.Testing for heterogeneity among the components of a binary composite outcome in a clinical trialIndividual and composite study endpoints: separating the wheat from the chaff.Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseReassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients--a systematic review and meta-analysis.From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertensionDelphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention.Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges.Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic reviewEfficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.Outcomes in registered, ongoing randomized controlled trials of patient education.Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological studyA randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation--a feasibility study.Therapeutic innovations, diminishing returns, and control rate preservationRethinking composite end points in clinical trials: insights from patients and trialists.Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-yearsAnalyzing composite outcomes in cardiovascular studies: traditional Cox proportional hazards versus quality-of-life-adjusted survival approaches.Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary careEndpoint selection and relative (versus absolute) risk reporting in published medication trials.Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trialsMethodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Waking up from the DREAM of preventing diabetes with drugs.
P2860
Q24289467-4AB588AA-7BCF-4A74-BED6-B83BF74E41C6Q24652537-ACD54B12-217E-4B99-AAB1-59A47E0253C3Q24707972-2C6B5D26-9757-4F19-8BC4-EE3FCDDE1D52Q26767278-861022C1-ECE3-4FA2-8D48-F67B866165D5Q26801620-27913E13-B186-45C8-A3D9-19AB57D7009DQ27012843-6E31962B-1BDD-4AA1-87CB-79E9504E2B94Q27027449-7B06D733-A593-43C7-9E20-10A9FFF745E2Q28533725-535AC993-D602-41D9-BF25-FFF9EEFD32B2Q28710019-58A166DC-181D-45D8-828E-2747BDA56D74Q28730540-77F36D3B-89E9-438C-B5FA-3635E6D476CAQ30396673-C53E45C7-A492-49BB-BD4C-03250BC5612BQ30435820-CDFBC735-7414-4FC4-87A2-B47228BC3123Q30860218-CAC2B1C8-415F-4E3E-A438-C8E48F0BD52FQ30871934-FC4C0CDC-8916-48A9-B409-8339A9F9F1C1Q31105054-A6BF0002-723B-42A4-A47D-884C9435FE6AQ33428766-F35AF4A1-7546-4777-9EA4-8915BD8427ECQ33501445-10C536CF-AE18-419F-B935-49477020D7FAQ33569474-AE240F98-ED30-4C62-9A70-B372D0064FF7Q33596793-1A3B8E95-0E69-4658-A847-5E2E6CC9B314Q33606234-65A783D5-528D-4DC8-A25B-5CFB170902BEQ33646625-C5A46405-04E5-41E8-833C-C20EFD6DF79CQ33776201-B263F5AA-C544-4F3E-8364-79E30C5A4CDFQ33806102-85D4C240-4BA1-410A-92CA-9109D5632C83Q33872146-C3668B06-4AF4-48C1-B695-6033ADC2E422Q33900204-C52197EE-CAA6-484D-829B-00EA56F1AE53Q34073347-BCD13805-FB58-4479-822E-657DEF7888A2Q34142678-3921974B-0DCC-4CD1-8509-44D7188EEAACQ34391137-6A8438EF-FF88-4D15-B1FD-A92E5047547CQ34567058-28C7741E-C8EB-4EE6-85C2-54955913FCA1Q34670467-11E47D70-B99D-402C-A1A2-241996F6D7CFQ34712057-5C20276E-889F-4FA8-92ED-C69D48534B12Q34766146-3F92798D-F215-4543-A233-9EE93992679EQ35029327-211769C7-2CB3-497B-8573-830194AC05B7Q35049849-7379AD6C-589A-4B51-B257-251C0D0B772CQ35240769-A21DA79C-3309-4589-9741-96CA1AC80268Q35397970-CB829B05-A3E2-4053-9806-C4593FAFD2F7Q35527067-D9E4E24F-DE42-489C-91F9-01C825DC2205Q35559489-D2003E8F-00F4-4FEB-96D6-C8A47116B4F8Q35752562-464ACF91-A2B1-4FCC-9D83-F1D326FA1DE8Q35763346-0ECCB1B8-DD6A-43E1-98ED-25E1CA02240D
P2860
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Problems with use of composite ...... randomised controlled trials.
@ast
Problems with use of composite ...... randomised controlled trials.
@en
type
label
Problems with use of composite ...... randomised controlled trials.
@ast
Problems with use of composite ...... randomised controlled trials.
@en
prefLabel
Problems with use of composite ...... randomised controlled trials.
@ast
Problems with use of composite ...... randomised controlled trials.
@en
P2093
P2860
P50
P1433
P1476
Problems with use of composite ...... randomised controlled trials.
@en
P2093
Andrew Worster
Antònia Domingo-Salvany
Diane Heels-Ansdell
Edward J Mills
Elie A Akl
Gaietà Permanyer-Miralda
Holger J Schünemann
Ignacio Ferreira-González
Jordi Alonso
Pablo Alonso-Coello
P2860
P356
10.1136/BMJ.39136.682083.AE
P407
P50
P577
2007-04-02T00:00:00Z